位置:首页 > 蛋白库 > GGT5_HUMAN
GGT5_HUMAN
ID   GGT5_HUMAN              Reviewed;         586 AA.
AC   P36269; Q53XM9; Q6GMP0; Q96FC1; Q9UFM5;
DT   01-JUN-1994, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 2.
DT   03-AUG-2022, entry version 195.
DE   RecName: Full=Glutathione hydrolase 5 proenzyme;
DE            EC=3.4.19.13 {ECO:0000269|PubMed:1676842, ECO:0000269|PubMed:21447318, ECO:0000269|PubMed:30842656};
DE   AltName: Full=Gamma-glutamyl transpeptidase-related enzyme {ECO:0000303|PubMed:1676842};
DE            Short=GGT-rel {ECO:0000303|PubMed:1676842};
DE   AltName: Full=Gamma-glutamyltransferase 5;
DE            Short=GGT 5;
DE            EC=2.3.2.2 {ECO:0000269|PubMed:21447318};
DE   AltName: Full=Gamma-glutamyltransferase-like activity 1 {ECO:0000303|PubMed:1676842};
DE   AltName: Full=Gamma-glutamyltranspeptidase 5;
DE   AltName: Full=Leukotriene-C4 hydrolase;
DE            EC=3.4.19.14 {ECO:0000269|PubMed:21447318};
DE   Contains:
DE     RecName: Full=Glutathione hydrolase 5 heavy chain;
DE   Contains:
DE     RecName: Full=Glutathione hydrolase 5 light chain;
DE   Flags: Precursor;
GN   Name=GGT5; Synonyms=GGTLA1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), VARIANT ARG-330, CATALYTIC
RP   ACTIVITY, AND FUNCTION.
RC   TISSUE=Placenta;
RX   PubMed=1676842; DOI=10.1073/pnas.88.14.6303;
RA   Heisterkamp N., Rajpert-De Meyts E., Uribe L., Forman H.J., Groffen J.;
RT   "Identification of a human gamma-glutamyl cleaving enzyme related to, but
RT   distinct from, gamma-glutamyl transpeptidase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 88:6303-6307(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
RL   Submitted (AUG-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=15461802; DOI=10.1186/gb-2004-5-10-r84;
RA   Collins J.E., Wright C.L., Edwards C.A., Davis M.P., Grinham J.A.,
RA   Cole C.G., Goward M.E., Aguado B., Mallya M., Mokrab Y., Huckle E.J.,
RA   Beare D.M., Dunham I.;
RT   "A genome annotation-driven approach to cloning the human ORFeome.";
RL   Genome Biol. 5:R84.1-R84.11(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Small intestine;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Fetal kidney;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT ARG-330.
RX   PubMed=10591208; DOI=10.1038/990031;
RA   Dunham I., Hunt A.R., Collins J.E., Bruskiewich R., Beare D.M., Clamp M.,
RA   Smink L.J., Ainscough R., Almeida J.P., Babbage A.K., Bagguley C.,
RA   Bailey J., Barlow K.F., Bates K.N., Beasley O.P., Bird C.P., Blakey S.E.,
RA   Bridgeman A.M., Buck D., Burgess J., Burrill W.D., Burton J., Carder C.,
RA   Carter N.P., Chen Y., Clark G., Clegg S.M., Cobley V.E., Cole C.G.,
RA   Collier R.E., Connor R., Conroy D., Corby N.R., Coville G.J., Cox A.V.,
RA   Davis J., Dawson E., Dhami P.D., Dockree C., Dodsworth S.J., Durbin R.M.,
RA   Ellington A.G., Evans K.L., Fey J.M., Fleming K., French L., Garner A.A.,
RA   Gilbert J.G.R., Goward M.E., Grafham D.V., Griffiths M.N.D., Hall C.,
RA   Hall R.E., Hall-Tamlyn G., Heathcott R.W., Ho S., Holmes S., Hunt S.E.,
RA   Jones M.C., Kershaw J., Kimberley A.M., King A., Laird G.K., Langford C.F.,
RA   Leversha M.A., Lloyd C., Lloyd D.M., Martyn I.D., Mashreghi-Mohammadi M.,
RA   Matthews L.H., Mccann O.T., Mcclay J., Mclaren S., McMurray A.A.,
RA   Milne S.A., Mortimore B.J., Odell C.N., Pavitt R., Pearce A.V., Pearson D.,
RA   Phillimore B.J.C.T., Phillips S.H., Plumb R.W., Ramsay H., Ramsey Y.,
RA   Rogers L., Ross M.T., Scott C.E., Sehra H.K., Skuce C.D., Smalley S.,
RA   Smith M.L., Soderlund C., Spragon L., Steward C.A., Sulston J.E.,
RA   Swann R.M., Vaudin M., Wall M., Wallis J.M., Whiteley M.N., Willey D.L.,
RA   Williams L., Williams S.A., Williamson H., Wilmer T.E., Wilming L.,
RA   Wright C.L., Hubbard T., Bentley D.R., Beck S., Rogers J., Shimizu N.,
RA   Minoshima S., Kawasaki K., Sasaki T., Asakawa S., Kudoh J., Shintani A.,
RA   Shibuya K., Yoshizaki Y., Aoki N., Mitsuyama S., Roe B.A., Chen F., Chu L.,
RA   Crabtree J., Deschamps S., Do A., Do T., Dorman A., Fang F., Fu Y., Hu P.,
RA   Hua A., Kenton S., Lai H., Lao H.I., Lewis J., Lewis S., Lin S.-P., Loh P.,
RA   Malaj E., Nguyen T., Pan H., Phan S., Qi S., Qian Y., Ray L., Ren Q.,
RA   Shaull S., Sloan D., Song L., Wang Q., Wang Y., Wang Z., White J.,
RA   Willingham D., Wu H., Yao Z., Zhan M., Zhang G., Chissoe S., Murray J.,
RA   Miller N., Minx P., Fulton R., Johnson D., Bemis G., Bentley D.,
RA   Bradshaw H., Bourne S., Cordes M., Du Z., Fulton L., Goela D., Graves T.,
RA   Hawkins J., Hinds K., Kemp K., Latreille P., Layman D., Ozersky P.,
RA   Rohlfing T., Scheet P., Walker C., Wamsley A., Wohldmann P., Pepin K.,
RA   Nelson J., Korf I., Bedell J.A., Hillier L.W., Mardis E., Waterston R.,
RA   Wilson R., Emanuel B.S., Shaikh T., Kurahashi H., Saitta S., Budarf M.L.,
RA   McDermid H.E., Johnson A., Wong A.C.C., Morrow B.E., Edelmann L., Kim U.J.,
RA   Shizuya H., Simon M.I., Dumanski J.P., Peyrard M., Kedra D., Seroussi E.,
RA   Fransson I., Tapia I., Bruder C.E., O'Brien K.P., Wilkinson P.,
RA   Bodenteich A., Hartman K., Hu X., Khan A.S., Lane L., Tilahun Y.,
RA   Wright H.;
RT   "The DNA sequence of human chromosome 22.";
RL   Nature 402:489-495(1999).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3).
RC   TISSUE=Brain, and PNS;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-550.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of multiple
RT   enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [10]
RP   CATALYTIC ACTIVITY, FUNCTION, BIOPHYSICOCHEMICAL PROPERTIES, AND SUBSTRATE
RP   SPECIFICITY.
RX   PubMed=21447318; DOI=10.1016/j.ab.2011.03.026;
RA   Wickham S., West M.B., Cook P.F., Hanigan M.H.;
RT   "Gamma-glutamyl compounds: substrate specificity of gamma-glutamyl
RT   transpeptidase enzymes.";
RL   Anal. Biochem. 414:208-214(2011).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [12]
RP   CATALYTIC ACTIVITY, AND FUNCTION.
RX   PubMed=30842656; DOI=10.1038/s41586-019-1003-z;
RA   Lu E., Wolfreys F.D., Muppidi J.R., Xu Y., Cyster J.G.;
RT   "S-Geranylgeranyl-L-glutathione is a ligand for human B cell-confinement
RT   receptor P2RY8.";
RL   Nature 567:244-248(2019).
CC   -!- FUNCTION: Cleaves the gamma-glutamyl peptide bond of glutathione and
CC       glutathione-S-conjugate such as leukotriene C4 (PubMed:21447318). Does
CC       not cleaves gamma-glutamyl compounds such as gamma-glutamyl leucine
CC       (PubMed:21447318). May also catalyze a transpeptidation reaction in
CC       addition to the hydrolysis reaction, transferring the gamma-glutamyl
CC       moiety to an acceptor amino acid to form a new gamma-glutamyl compound
CC       (PubMed:21447318). Acts as a negative regulator of geranylgeranyl
CC       glutathione bioactivity by cleaving off its gamma-glutamyl group,
CC       playing a role in adaptive immune responses (PubMed:30842656).
CC       {ECO:0000269|PubMed:21447318, ECO:0000269|PubMed:30842656}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=an alpha-amino acid + an N-terminal (5-L-glutamyl)-[peptide] =
CC         5-L-glutamyl amino acid + N-terminal L-alpha-aminoacyl-[peptide];
CC         Xref=Rhea:RHEA:23904, Rhea:RHEA-COMP:9780, Rhea:RHEA-COMP:9795,
CC         ChEBI:CHEBI:77644, ChEBI:CHEBI:78597, ChEBI:CHEBI:78599,
CC         ChEBI:CHEBI:78608; EC=2.3.2.2;
CC         Evidence={ECO:0000269|PubMed:21447318};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:23905;
CC         Evidence={ECO:0000305};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=glutathione + H2O = L-cysteinylglycine + L-glutamate;
CC         Xref=Rhea:RHEA:28807, ChEBI:CHEBI:15377, ChEBI:CHEBI:29985,
CC         ChEBI:CHEBI:57925, ChEBI:CHEBI:61694; EC=3.4.19.13;
CC         Evidence={ECO:0000269|PubMed:1676842, ECO:0000269|PubMed:21447318};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:28808;
CC         Evidence={ECO:0000305};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + leukotriene C4 = L-glutamate + leukotriene D4;
CC         Xref=Rhea:RHEA:31563, ChEBI:CHEBI:15377, ChEBI:CHEBI:29985,
CC         ChEBI:CHEBI:57973, ChEBI:CHEBI:63166; EC=3.4.19.14;
CC         Evidence={ECO:0000269|PubMed:21447318};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:31564;
CC         Evidence={ECO:0000305|PubMed:21447318};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=an S-substituted glutathione + H2O = an S-substituted L-
CC         cysteinylglycine + L-glutamate; Xref=Rhea:RHEA:59468,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:29985, ChEBI:CHEBI:90779,
CC         ChEBI:CHEBI:143103; EC=3.4.19.13;
CC         Evidence={ECO:0000269|PubMed:21447318, ECO:0000269|PubMed:30842656};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:59469;
CC         Evidence={ECO:0000305};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + S-[(2E,6E,10E)-geranylgeranyl]-L-glutathione = L-
CC         glutamate + S-[(2E,6E,10E)-geranylgeranyl]-L-cysteinylglycine;
CC         Xref=Rhea:RHEA:65120, ChEBI:CHEBI:15377, ChEBI:CHEBI:29985,
CC         ChEBI:CHEBI:156326, ChEBI:CHEBI:156330;
CC         Evidence={ECO:0000269|PubMed:30842656};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:65121;
CC         Evidence={ECO:0000305|PubMed:30842656};
CC   -!- ACTIVITY REGULATION: Inhibited by serine-borate.
CC       {ECO:0000269|PubMed:21447318}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=10.5 uM for glutathione {ECO:0000269|PubMed:21447318};
CC         KM=10.2 uM for leukotriene C4 {ECO:0000269|PubMed:21447318};
CC         KM=18.2 uM for S-methylglutathione {ECO:0000269|PubMed:21447318};
CC         KM=14.8 uM for S-(4-nitro-benzyl)glutathione
CC         {ECO:0000269|PubMed:21447318};
CC         KM=43 uM for oxidized glutathione {ECO:0000269|PubMed:21447318};
CC   -!- PATHWAY: Sulfur metabolism; glutathione metabolism.
CC       {ECO:0000269|PubMed:21447318}.
CC   -!- PATHWAY: Lipid metabolism; leukotriene D4 biosynthesis.
CC       {ECO:0000269|PubMed:21447318}.
CC   -!- SUBUNIT: Heterodimer composed of the light and heavy chains. The active
CC       site is located in the light chain. {ECO:0000250|UniProtKB:Q9Z2A9}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000250|UniProtKB:Q9Z2A9}; Single-
CC       pass type II membrane protein {ECO:0000250|UniProtKB:Q9Z2A9}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=P36269-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P36269-2; Sequence=VSP_008146;
CC       Name=3;
CC         IsoId=P36269-3; Sequence=VSP_043470;
CC   -!- PTM: Cleaved by autocatalysis into a large and a small subunit.
CC       {ECO:0000250|UniProtKB:P19440}.
CC   -!- PTM: Glycosylated. {ECO:0000250|UniProtKB:Q9Z2A9}.
CC   -!- MISCELLANEOUS: A previous study reported that GSH and oxidized
CC       glutathione (GSSG) are not substrates for murine GGT5 (By similarity).
CC       However, this result contrasts with two studies reported that GSH is
CC       indeed a substrate for GGT5 (PubMed:21447318, PubMed:1676842).
CC       {ECO:0000250|UniProtKB:Q9Z2A9, ECO:0000269|PubMed:1676842,
CC       ECO:0000269|PubMed:21447318}.
CC   -!- SIMILARITY: Belongs to the gamma-glutamyltransferase family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAB55910.1; Type=Frameshift; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M64099; AAA58503.1; -; mRNA.
DR   EMBL; AL117414; CAB55910.1; ALT_FRAME; mRNA.
DR   EMBL; BT009808; AAP88810.1; -; mRNA.
DR   EMBL; CT841518; CAJ86448.1; -; mRNA.
DR   EMBL; AK292006; BAF84695.1; -; mRNA.
DR   EMBL; AP000353; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AP000354; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471095; EAW59643.1; -; Genomic_DNA.
DR   EMBL; BC011362; AAH11362.1; -; mRNA.
DR   EMBL; BC073999; AAH73999.1; -; mRNA.
DR   CCDS; CCDS13825.1; -. [P36269-1]
DR   CCDS; CCDS42989.1; -. [P36269-2]
DR   CCDS; CCDS42990.1; -. [P36269-3]
DR   PIR; A41125; A41125.
DR   PIR; T17220; T17220.
DR   RefSeq; NP_001093251.1; NM_001099781.2. [P36269-3]
DR   RefSeq; NP_001093252.1; NM_001099782.2. [P36269-2]
DR   RefSeq; NP_001289393.1; NM_001302464.1.
DR   RefSeq; NP_001289394.1; NM_001302465.1.
DR   RefSeq; NP_004112.2; NM_004121.3. [P36269-1]
DR   AlphaFoldDB; P36269; -.
DR   SMR; P36269; -.
DR   BioGRID; 108954; 69.
DR   IntAct; P36269; 5.
DR   STRING; 9606.ENSP00000381340; -.
DR   SwissLipids; SLP:000001455; -.
DR   MEROPS; T03.002; -.
DR   GlyGen; P36269; 8 sites, 4 O-linked glycans (2 sites).
DR   iPTMnet; P36269; -.
DR   PhosphoSitePlus; P36269; -.
DR   BioMuta; GGT5; -.
DR   DMDM; 116242493; -.
DR   EPD; P36269; -.
DR   jPOST; P36269; -.
DR   MassIVE; P36269; -.
DR   MaxQB; P36269; -.
DR   PaxDb; P36269; -.
DR   PeptideAtlas; P36269; -.
DR   PRIDE; P36269; -.
DR   ProteomicsDB; 55177; -. [P36269-1]
DR   ProteomicsDB; 55178; -. [P36269-2]
DR   ProteomicsDB; 55179; -. [P36269-3]
DR   Antibodypedia; 285; 130 antibodies from 27 providers.
DR   DNASU; 2687; -.
DR   Ensembl; ENST00000263112.11; ENSP00000263112.7; ENSG00000099998.19. [P36269-2]
DR   Ensembl; ENST00000327365.10; ENSP00000330080.4; ENSG00000099998.19. [P36269-1]
DR   Ensembl; ENST00000398292.3; ENSP00000381340.3; ENSG00000099998.19. [P36269-3]
DR   GeneID; 2687; -.
DR   KEGG; hsa:2687; -.
DR   MANE-Select; ENST00000327365.10; ENSP00000330080.4; NM_004121.5; NP_004112.2.
DR   UCSC; uc002zzo.4; human. [P36269-1]
DR   CTD; 2687; -.
DR   DisGeNET; 2687; -.
DR   GeneCards; GGT5; -.
DR   HGNC; HGNC:4260; GGT5.
DR   HPA; ENSG00000099998; Low tissue specificity.
DR   MIM; 137168; gene.
DR   neXtProt; NX_P36269; -.
DR   OpenTargets; ENSG00000099998; -.
DR   PharmGKB; PA162389442; -.
DR   VEuPathDB; HostDB:ENSG00000099998; -.
DR   eggNOG; KOG2410; Eukaryota.
DR   GeneTree; ENSGT00940000155794; -.
DR   HOGENOM; CLU_014813_4_1_1; -.
DR   InParanoid; P36269; -.
DR   OMA; VCGMGPP; -.
DR   OrthoDB; 1419292at2759; -.
DR   PhylomeDB; P36269; -.
DR   TreeFam; TF313608; -.
DR   BioCyc; MetaCyc:HS01949-MON; -.
DR   BRENDA; 2.3.2.2; 2681.
DR   BRENDA; 3.4.19.13; 2681.
DR   PathwayCommons; P36269; -.
DR   Reactome; R-HSA-174403; Glutathione synthesis and recycling.
DR   Reactome; R-HSA-2142691; Synthesis of Leukotrienes (LT) and Eoxins (EX).
DR   Reactome; R-HSA-5423646; Aflatoxin activation and detoxification.
DR   Reactome; R-HSA-9664535; LTC4-CYSLTR mediated IL4 production.
DR   Reactome; R-HSA-9753281; Paracetamol ADME.
DR   SignaLink; P36269; -.
DR   UniPathway; UPA00204; -.
DR   UniPathway; UPA00880; -.
DR   BioGRID-ORCS; 2687; 20 hits in 1076 CRISPR screens.
DR   ChiTaRS; GGT5; human.
DR   GeneWiki; GGTLA1; -.
DR   GenomeRNAi; 2687; -.
DR   Pharos; P36269; Tbio.
DR   PRO; PR:P36269; -.
DR   Proteomes; UP000005640; Chromosome 22.
DR   RNAct; P36269; protein.
DR   Bgee; ENSG00000099998; Expressed in right lobe of thyroid gland and 127 other tissues.
DR   ExpressionAtlas; P36269; baseline and differential.
DR   Genevisible; P36269; HS.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0031226; C:intrinsic component of plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0036374; F:glutathione hydrolase activity; IDA:UniProtKB.
DR   GO; GO:0102953; F:hypoglycin A gamma-glutamyl transpeptidase activity; IEA:UniProtKB-EC.
DR   GO; GO:0103068; F:leukotriene C4 gamma-glutamyl transferase activity; IEA:UniProtKB-EC.
DR   GO; GO:0002951; F:leukotriene-C(4) hydrolase; IDA:UniProtKB.
DR   GO; GO:0000048; F:peptidyltransferase activity; IDA:BHF-UCL.
DR   GO; GO:0006520; P:cellular amino acid metabolic process; IDA:UniProtKB.
DR   GO; GO:0006631; P:fatty acid metabolic process; IDA:BHF-UCL.
DR   GO; GO:0006750; P:glutathione biosynthetic process; IEA:UniProtKB-KW.
DR   GO; GO:0006751; P:glutathione catabolic process; IDA:UniProtKB.
DR   GO; GO:0006954; P:inflammatory response; IBA:GO_Central.
DR   GO; GO:1901750; P:leukotriene D4 biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0006508; P:proteolysis; IDA:UniProtKB.
DR   Gene3D; 1.10.246.130; -; 1.
DR   Gene3D; 3.60.20.40; -; 1.
DR   InterPro; IPR043138; GGT_lsub_C.
DR   InterPro; IPR000101; GGT_peptidase.
DR   InterPro; IPR043137; GGT_ssub.
DR   InterPro; IPR029055; Ntn_hydrolases_N.
DR   PANTHER; PTHR11686; PTHR11686; 1.
DR   SUPFAM; SSF56235; SSF56235; 1.
DR   PROSITE; PS00462; G_GLU_TRANSPEPTIDASE; 1.
PE   1: Evidence at protein level;
KW   Acyltransferase; Alternative splicing; Glutathione biosynthesis;
KW   Glycoprotein; Hydrolase; Leukotriene biosynthesis; Membrane; Protease;
KW   Reference proteome; Signal-anchor; Transferase; Transmembrane;
KW   Transmembrane helix; Zymogen.
FT   CHAIN           1..387
FT                   /note="Glutathione hydrolase 5 heavy chain"
FT                   /evidence="ECO:0000250|UniProtKB:P19440"
FT                   /id="PRO_0000011072"
FT   CHAIN           388..586
FT                   /note="Glutathione hydrolase 5 light chain"
FT                   /evidence="ECO:0000250|UniProtKB:P19440"
FT                   /id="PRO_0000011073"
FT   TOPO_DOM        1..8
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Z2A9"
FT   TRANSMEM        9..29
FT                   /note="Helical; Signal-anchor for type II membrane protein"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Z2A9"
FT   TOPO_DOM        30..586
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Z2A9"
FT   ACT_SITE        388
FT                   /note="Nucleophile"
FT                   /evidence="ECO:0000250|UniProtKB:P19440"
FT   BINDING         110
FT                   /ligand="L-glutamate"
FT                   /ligand_id="ChEBI:CHEBI:29985"
FT                   /evidence="ECO:0000250|UniProtKB:P19440"
FT   BINDING         406
FT                   /ligand="L-glutamate"
FT                   /ligand_id="ChEBI:CHEBI:29985"
FT                   /evidence="ECO:0000250|UniProtKB:P19440"
FT   BINDING         427
FT                   /ligand="L-glutamate"
FT                   /ligand_id="ChEBI:CHEBI:29985"
FT                   /evidence="ECO:0000250|UniProtKB:P19440"
FT   BINDING         469..470
FT                   /ligand="L-glutamate"
FT                   /ligand_id="ChEBI:CHEBI:29985"
FT                   /evidence="ECO:0000250|UniProtKB:P19440"
FT   CARBOHYD        98
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        204
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        303
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        347
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        535
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        550
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:19159218"
FT   VAR_SEQ         101..132
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:17974005"
FT                   /id="VSP_008146"
FT   VAR_SEQ         445
FT                   /note="P -> PA (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_043470"
FT   VARIANT         11
FT                   /note="L -> I (in dbSNP:rs5760274)"
FT                   /id="VAR_028006"
FT   VARIANT         330
FT                   /note="K -> R (in dbSNP:rs2275984)"
FT                   /evidence="ECO:0000269|PubMed:10591208,
FT                   ECO:0000269|PubMed:1676842"
FT                   /id="VAR_028007"
FT   VARIANT         332
FT                   /note="Q -> H (in dbSNP:rs6004105)"
FT                   /id="VAR_028008"
FT   VARIANT         475
FT                   /note="I -> V (in dbSNP:rs7288201)"
FT                   /id="VAR_024455"
FT   CONFLICT        408
FT                   /note="N -> Y (in Ref. 5; CAB55910)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        437
FT                   /note="R -> W (in Ref. 1; AAA58503)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   586 AA;  62261 MW;  EE37B3CE516F5788 CRC64;
     MARGYGATVS LVLLGLGLAL AVIVLAVVLS RHQAPCGPQA FAHAAVAADS KVCSDIGRAI
     LQQQGSPVDA TIAALVCTSV VNPQSMGLGG GVIFTIYNVT TGKVEVINAR ETVPASHAPS
     LLDQCAQALP LGTGAQWIGV PGELRGYAEA HRRHGRLPWA QLFQPTIALL RGGHVVAPVL
     SRFLHNSILR PSLQASTLRQ LFFNGTEPLR PQDPLPWPAL ATTLETVATE GVEVFYTGRL
     GQMLVEDIAK EGSQLTLQDL AKFQPEVVDA LEVPLGDYTL YSPPPPAGGA ILSFILNVLR
     GFNFSTESMA RPEGRVNVYH HLVETLKFAK GQRWRLGDPR SHPKLQNASR DLLGETLAQL
     IRQQIDGRGD HQLSHYSLAE AWGHGTGTSH VSVLGEDGSA VAATSTINTP FGAMVYSPRT
     GIILNNELLD LCERCPRGSG TTPSPVSGDR VGGAPGRCWP PVPGERSPSS MVPSILINKA
     QGSKLVIGGA GGELIISAVA QAIMSKLWLG FDLRAAIAAP ILHVNSKGCV EYEPNFSQEV
     QRGLQDRGQN QTQRPFFLNV VQAVSQEGAC VYAVSDLRKS GEAAGY
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024